|
|
|
Corporate Profile: Peptinnovate
| Summary: |
Peptinnovate is focused on the research and development of treatments for patients with inflammatory disorders based on proteins and peptides derived from Mycobacterium tuberculosis (TB) which are known to modulate the immune response to infection.
|
| Address (HQ): |
90 High Holborn
London, WC1V 6XX
United Kingdom |
| Phone
#'s (HQ): |
| Main |
+44 07703 194 341 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s (HQ): |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| not known |
| Internet
job postings: |
| not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications mentioning company on PubMed: publications
link. |
|
|
|
